Case Studies


Indication: NSCLC (Non Small Cell Lung Cancer)

A phase III double blind, randomized study in patients with NSCLC

Read More

Optimization of statistical analysis, key to best results!

At times, some clinical data seems insignificant and this might cause loss of highly crucial information and wrong inference about the study. Our statistics team makes sure that such data is not overlooked and is further exploited to yield optimum results.

PDF Read More

A complex oncology clinical study report

CSRs, and other regulatory documents, besides experience in writing manuscripts for medical journals. Thanks to the robust medical writing process followed at MakroCare that involves drafting in conjunction with subject experts and biostatisticians, and a series of critical reviews including editorial reviews followed by a stringent quality review, MakroCare delivered a top notch CSR to client.

PDF Read More

Time & Cost Effective Management of Voluminous Clinical Data is Easier Than You Think!

MakroCare is the right partner for Pharmaceutical companies performing clinical trials with its expertise and available resources for managing paper based, voluminous clinical data running into tens of thousands of pages.

PDF Read More

Aim:To assess efficacy & safety of the study drug in patients with Metastatic Breast Cancer

Phase III, double‐blind, placebo controlled, randomized study with 20 months per patient clinical duration

PDF Read More

Have Questions? Need Info/Quotes?